Find a Research Study in Tampa
Table of Contents
299+
Conducted
on Different
Patients
Our Clinical Trials Process
1. Pre-Screening
2. Informed Consent
3. Screening Visit
4. Enrollment
5. Follow Up Visits
6. End Of Study
299+
97%
+1K
98%
Lupus
Some individuals have a greater chance of developing lupus due to things like infections, medications, and even exposure to sunlight. Even though there is not currently a cure for lupus, there are treatments available that can help manage symptoms.
Details
- Phase: 2
- Study Type: Randomized Double blind placebo controlled.
- Insurance: no
- Duration: 1 year
- Benefits: $100 per visit
Qualifications
- From 18 to 85 years of age
- Diagnosis of SCLE or DLE documented in medical history.
- Historical skin biopsy within 10 years prior to Screening visit and confirmation of current diagnosis by skin photography at Screening visit.
Excluding
Lupus Nephrtis, Epilepsy, significant cardiovascular diseases, HIV, TB
Diabetes Mellitus Type 2
There is no cure for type 2 diabetes, but our goal is to help improve the lives of our patients through research.
Details
- Phase: 3
- Study Type: Double Blind Placebo
- Duration: 1 year
- Insurance: no
- Benefits: $100
Qualifications
- Male and female subjects aged 18 – 75 years.
- Established diagnosis of T2 Diabetes Mellitus for at least 6 months prior to Screening AND an A1C ≥ 7.5% but ≤ 11.0% at Screening.
- On a stable dose of a oral glucose-lowering agents for a period of 3 months prior to Screening.
Excluding
Lupus Nephrtis, Epilepsy, significant cardiovascular diseases, HIV, TB
Asthma
Asthma cannot be cured, but its symptoms can be controlled and our goal is to extend the range of control of the disease.
Details
- Phase: 2
- Study Type: Randomized Double Blind Placebo
- Duration: 12 weeks
- Insurance: no
- Benefits: $100 per visit
Qualifications
- 18 to 55 years of age inclusive at the time of signing the informed consent at Visit 1
- Documented asthma diagnosis ≥ 12 months prior to Visit 1
- Able to perform acceptable lung function testing.
Excluding
Mild Asthma ( should be Moderate to Severe)
Vaccine
The process of finding a vaccine candidate drug begins with preclinical evaluations. These evaluations could involve high throughput screening and selecting the proper antigen to invoke an immune response.
Details
- Phase: I/ II
- Study Type: open label
- Duration: 8 visits
- Insurance: no
- Benefits: $100 per visit
Qualifications
- Males and females who are at least 75 years of age at time of enrollment
- Good general health
- Available for the duration of the study
- Peripheral veins suitable for blood draw
Excluding
No steroids, younger than
Different Phases of Clinical Trials
Phase I
Within a small group of first-time participants, researchers test an experimental study drug or treatment.
Phase II
Then, in order to determine its effectiveness and more precisely evaluate the experimental drug or treatment, it is administered to a larger group of people.
Phase III
The experimental drug or treatment is given to large groups of people, confirm its efficacy and keep track of side effects.
Phase IV
For additional information, post-marketing studies, which are conducted after the FDA approves a treatment for use, are discussed.
Migraine
Improving the quality of life for people with migraine by eliminating the pain and other discomfort associated with migraine episodes is our goal.
Details
- Start Date: -
- Phase:Â Phase 2
- Study Type:Â Interventional
- Duration:Â 3 Visits
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $450 for time and travel
Qualifications
- From 18 to 65 years of age
- Migraine attacks, on average, lasting for 4 to 72 hours if untreated
- Migraine headaches frequency of 2 to 8 attacks of moderate or severe pain intensity per month
- Has at least 1-year history of migraine
Excluding
- Diagnosis of headache condition other than migraine
- History of cardiovascular disease
- Current use of opioids or cannabis
- Have a current diagnosis of significant psychiatric illness
Covid-19
Even today, clinical trials are still being carried out that will help combat future strains of the virus through innovative and safe treatments.
Details
- Start Date: -
- Phase:Â Phase 2
- Study Type:Â Interventional
- Duration:Â 7 Visits
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $1,500 for time and travel
Qualifications
- Participant ≥ 18 years of age
- Confirmed SARS-CoV-2 infection as determined by RT-PCR
- Initial onset of signs/symptoms attributable to COVID-19 within 5 days
- Has at least 1 medical condition
Excluding
- History of hospitalization
- Known medical history of active liver disease
- Known HIV infection
- Prior to the current disease episode, any confirmed SARS-CoV-2 infection
Alzheimer’s Disease
Volunteers who are at risk of developing symptoms of Alzheimer's disease as they age are central to our studies.
Details
- Start Date: -
- Phase:Â Phase 2
- Study Type:Â Interventional
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $1,500 for time and travel
Qualifications
- From 50 to 90 years of age
- Have a clinical diagnosis of mild-to-moderate Alzheimer’s disease
- Have a reliable caregiver
- Able to swallow oral medication
Excluding
- Have a current diagnosis of significant psychiatric illness
- Untreated clinical depression
- Have a history of cancer
- Clear evidence for other causes of neurodegeneration or dementia
- Significant ongoing psychiatric or substance abuse problems
Respiratory Syncytial Virus
The virus (RSV) can cause significant respiratory problems similar to those of a common cold.
Details
- Start Date: -
- Phase:Â Phase 2
- Study Type:Â Interventional
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $500 for time and travel
Qualifications
- From 18 to 85 years of age
- Diagnosis of Acute RSV infection
- Tested Positive for RSV infection
- Initial onset of signs/symptoms attributed to RSV within 5 days
Excluding
- Presence of clinically significant heart arrhythmias
- Known hepatitis B or C infection
- Confirmed SARS-CoV-2 Infection
- Women who are pregnant or breastfeeding
Traumatic Brain Injury
A TBI can have wide-ranging physical and psychological effects. Some symptoms may appear right after the traumatic event, while others may appear days or weeks later.
Details
- Start Date: -
- Phase:Â Phase 2
- Study Type:Â Interventional
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $2,000 for time and travel
Qualifications
- From 18 to 75 years of age
- History confirmed by evidence from medical information
- Must have had no further head trauma in the last 6 months
- Must have TBI
Excluding
- Progressive dementia
- Penetrating head trauma
- Significant symptoms of a depressive disorder
- Significant ongoing psychiatric or substance abuse problems
- Clinically significant or unstable systemic disease
Alzheimer’s Disease Phase 1
Details
- Start Date: -
- Phase:Â Phase 1
- Study Type:Â Interventional
- Insurance:Â No insurance is needed
- Benefits:Â Compensation up to $2,000 for time and travel
Qualifications
- From 55 to 85 years of age
- Must have a reliable informant or caregiver
- Participant weight at least 41 Kg (90 lbs) and not more than 113 Kg (250 lbs)
- Meet all criteria for MCI due to AD or mild Alzheimer's Disease
Excluding
- Patients who received any investigational biological drug within less than 1 year
- Has any contraindications for MRI
- Current important illness or unstable clinically
- Any suicide attempt
Federally Regulated Safeguards To Ensure Volunteer Protections
US Department of Health and Human Services
Food and Drug Administration (FDA)
Office for Human Research Protections
Clinical trial approval and monitoring by an Institutional Review Board (IRB)
Future Clinical Research Studies
Parkinson’s Disease
Dyslipidemia
Leukemia
Bipolar Disorder
Nicotine Dependence
Hypertension
Informed Consent
